Drag

Biofil Chemicals & Pharmaceuticals Limited

Healthcare BIOFILCHEM

41.71INR
-4.63 ( -9.99%)

Last update at

Day Range

41.7146.34
LowHigh

52 Week Range

32.16 62.88
LowHigh

Fundamentals

  • Previous Close 46.34
  • Market Cap 543.73M
  • Volume346,489
  • P/E Ratio 18.98
  • EBITDA 36.46M
  • Revenue TTM 455.49M
  • Revenue Per Share TTM 27.85
  • Gross Profit TTM 51.94M
  • Diluted EPS TTM 1.75

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 7.36M 8.65M 7.93M 10.15M 19.19M
Net income 5.58M 7.09M 5.60M 6.98M 12.41M
Total Revenue 334.02M 400.35M 300.35M 223.82M 357.50M
Gross Profit 20.92M 25.28M 21.38M 29.22M 33.24M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 509.60M 470.83M 314.06M 187.32M 332.38M
Intangible assets - - - - -
Other current assets 6.42M 5.45M 6.51M 2.48M 0.00M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -20.28M 22.46M -1.07M -2.96M 1.85M
Operating Cash -19.24M 23.94M -1.12M -2.20M 11.11M
Free Cash Flow -20.24M 23.71M -1.22M -2.90M 5.44M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Limited 		-4.63 -9.99% 41.71 543.73 18.98
SUNPHARMA
Sun Pharmaceutical Industries Limited 		4.50 0.26% 1706.60 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-169.50 -2.73% 6039.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-13.30 -0.33% 4032.30 1362716.66 63.48
CIPLA
Cipla Limited 		4.30 0.33% 1327.10 1183505.97 21.74

Profile

Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India.

Biofil Chemicals & Pharmaceuticals Limited

11/12, Sector 'E', Indore, India, 452015

Key Executives

Name Title Year Born
Mr. Ketan Shah COO & Whole Time Director 1961
Ms. Shikha Khilwani Company Sec. & Compliance Officer 1989
Mr. Ramesh S. Shah Chairman, CEO & MD 1936
Mr. Pawan Singh Rajput Chief Financial Officer 1990
Joseph Chacko Head of Admin. 1961
Akshay Atri Marketing Mang. 1991
Vinayak Bhopte Chief Chemist 1974
Mr. Ketan Shah MD & Chairman 1961
Mr. Pavan Singh Rajput Chief Financial Officer 1991
Joseph Chacko Head of Administration 1961

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.